AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26

Authors: Williams, LE Beatty, BG Shively, JE Beatty, JD
Citation: Le. Williams et al., Accumulation of radiolabeled anti-CEA antibody (mT84.66) in the case of multiple LS174T tumors in a nude mouse model, CANC BIO R, 16(2), 2001, pp. 147-157

Authors: Williams, LE Wu, AM Yazaki, PJ Liu, A Raubitschek, AA Shively, JE Wong, JYC
Citation: Le. Williams et al., Numerical selection of optimal tumor imaging agents with application to engineered antibodies, CANC BIO R, 16(1), 2001, pp. 25-35

Authors: Yazaki, PJ Wu, AM Tsai, SW Williams, LE Ikle, DN Wong, JYC Shively, JE Raubitschek, AA
Citation: Pj. Yazaki et al., Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and T84.66 minibody: Comparison to radioiodinated fragments, BIOCONJ CHE, 12(2), 2001, pp. 220-228

Authors: Tsai, SW Li, L Williams, LE Anderson, AL Raubitschek, A Shively, JE
Citation: Sw. Tsai et al., Metabolism and renal clearance of In-111-labeled DOTA-conjugated antibody fragments, BIOCONJ CHE, 12(2), 2001, pp. 264-270

Authors: Lewis, MR Kao, JY Anderson, ALJ Shively, JE Raubitschek, A
Citation: Mr. Lewis et al., An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA, BIOCONJ CHE, 12(2), 2001, pp. 320-324

Authors: Dernell, WS Gentry-Weeks, C Manning, MC Powers, BE Park, RD Lafferty, M Kuntz, CA Shively, JE Falk, RF Meyer, JD Randolph, TW Withrow, SJ
Citation: Ws. Dernell et al., In vivo evaluation of antibiotic impregnated beads in a rat osteomyelitis model, J BIOACT C, 16(3), 2001, pp. 235-250

Authors: Dernell, WS Withrow, SJ Kuntz, CA Dewell, R Garry, FB Powers, BE Shively, JE Meyer, JD Manning, MC Falk, RF Randolph, TW
Citation: Ws. Dernell et al., In vivo evaluation of gentamicin impregnated polylactic acid beads implanted in sheep, J BIOACT C, 16(2), 2001, pp. 119-135

Authors: Yazaki, PJ Shively, L Clark, C Cheung, CW Le, W Szpikowska, B Shively, JE Raubitschek, AA Wu, AM
Citation: Pj. Yazaki et al., Mammalian expression and hollow fiber bioreactor production of recombinantanti-CEA diabody and minibody for clinical applications, J IMMUNOL M, 253(1-2), 2001, pp. 195-208

Authors: Hoffmann, P Mueller, N Shively, JE Fleischer, B Neumaier, M
Citation: P. Hoffmann et al., Fusion proteins of B7.1 and a carcinoembryonic antigen (CEA)-specific antibody fragment opsonize CEA-expressing tumor cells and coactivate T-cell immunity, INT J CANC, 92(5), 2001, pp. 725-732

Authors: Keire, DA Jang, YH Li, L Dasgupta, S Goddard, WA Shively, JE
Citation: Da. Keire et al., Chelators for radioimmunotherapy: 1. NMR and ab initio calculation studieson 1,4,7,10-tetra(carboxyethyl)-1,4,7,10-tetraazacyclodedecane (DO4Pr) and1,4,7-tris(carboxymethyl)-10-(carboxyethyl)-1,4,7,10-tetraazacyclododecane(DO3A1Pr), INORG CHEM, 40(17), 2001, pp. 4310-4318

Authors: Wong, JYC Chu, DZ Yamauchi, DM Williams, LE Liu, A Wilczynski, S Wu, AM Shively, JE Doroshow, JH Raubitschek, AA
Citation: Jyc. Wong et al., A phase I radioimmunotherapy trial evaluating (90)yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84,66 in patients with metastatic CEA-producing malignancies, CLIN CANC R, 6(10), 2000, pp. 3855-3863

Authors: Tsai, SW Sun, YY Williams, LE Raubitschek, AA Wu, AM Shively, JE
Citation: Sw. Tsai et al., Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5, BIOCONJ CHE, 11(3), 2000, pp. 327-334

Authors: Wong, JYC Wang, JY Liu, AL Odom-Maryon, T Shively, JE Raubitschek, AA Williams, LE
Citation: Jyc. Wong et al., Evaluating changes in stable chromosomal translocation frequency in patients receiving radioimmunotherapy, INT J RAD O, 46(3), 2000, pp. 599-607

Authors: Wu, AM Yazaki, PJ Tsai, SW Nguyen, K Anderson, AL McCarthy, DW Welch, MJ Shively, JE Williams, LE Raubitschek, AA Wong, JYC Toyokuni, T Phelps, ME Gambhir, SS
Citation: Am. Wu et al., High-resolution microPET imaging of carcino-embryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment, P NAS US, 97(15), 2000, pp. 8495-8500

Authors: Xu, XC Clarke, P Szalai, G Shively, JE Williams, LE Shyr, Y Shi, EG Primus, FJ
Citation: Xc. Xu et al., Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein, CANCER RES, 60(16), 2000, pp. 4475-4484

Authors: Shively, JE
Citation: Je. Shively, The chemistry of protein sequence analysis, EXS, 88, 2000, pp. 99-117

Authors: Wu, AM Williams, LE Zieran, L Padma, A Sherman, M Bebb, GG Odom-Maryon, T Wong, JYC Shively, JE Raubitschek, AA
Citation: Am. Wu et al., Anti-carcinoembryonic antigen (CEA) diabody for rapid tumor targeting and imaging, TUMOR TARG, 4(1), 1999, pp. 47-58

Authors: Wong, JYC Somlo, G Odom-Maryon, T Williams, LE Liu, A Yamauchi, D Wu, AM Yazaki, P Wilczynski, S Shively, JE Forman, S Doroshow, JH Raubitschek, AA
Citation: Jyc. Wong et al., Initial clinical experience evaluating yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer, CLIN CANC R, 5(10), 1999, pp. 3224S-3231S

Authors: Hellwig, S Robin, F Drossard, J Raven, NPG Vaquero-Martin, C Shively, JE Fischer, W
Citation: S. Hellwig et al., Production of carcinoembryonic antigen (CEA) N-A3 domain in Pichia pastoris by fermentation, BIOT APP B, 30, 1999, pp. 267-275

Authors: Neumaier, M Gaida, FJ Lewis, MR Hefta, LJ Shively, LE Raubitschek, A Shively, JE
Citation: M. Neumaier et al., A chimeric anti-CEA antibody with heavy interchain disulfide bonds deleted: Molecular characterization and biodistributions in normal and tumor bearing mice, ANTICANC R, 19(1A), 1999, pp. 13-21

Authors: Huang, J Hardy, JD Sun, YY Shively, JE
Citation: J. Huang et al., Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F, J CELL SCI, 112(23), 1999, pp. 4193-4205

Authors: Beauchemin, N Draber, P Dveksler, G Gold, P Gray-Owen, S Grunert, F Hammarstrom, S Holmes, KV Karlsson, A Kuroki, M Lin, SH Lucka, L Najjar, SM Neumaier, M Obrink, B Shively, JE Skubitz, KM Stanners, CP Thomas, P Thompson, JA Virji, M von Kleist, S Wagener, C Watt, S Zimmermann, W
Citation: N. Beauchemin et al., Redefined nomenclature for members of the carcinoembryonic antigen family, EXP CELL RE, 252(2), 1999, pp. 243-249

Authors: Jang, YH Blanco, M Dasgupta, S Keire, DA Shively, JE Goddard, WA
Citation: Yh. Jang et al., Mechanism and energetics for complexation of Y-90 with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), a model for cancer radioimmunotherapy, J AM CHEM S, 121(26), 1999, pp. 6142-6151

Authors: You, YH Hefta, LJ Yazaki, PJ Wu, AM Shively, JE
Citation: Yh. You et al., Expression, purification, and characterization of a two domain carcinoembryonic antigen minigene (N-A3) in Pichia pastoris. The essential role of theN-domain, ANTICANC R, 18(5A), 1998, pp. 3193-3201

Authors: Huang, J Simpson, JF Glackin, C Riethorf, L Wagener, C Shively, JE
Citation: J. Huang et al., Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells, ANTICANC R, 18(5A), 1998, pp. 3203-3212
Risultati: 1-25 | 26-26